Sellke Nicholas, Gordon Caroline, Lawandy Isabella, Gorvitovskaia Anastassia Y, Scrimgeour Laura A, Fingleton James G, Sellke Frank W, Feng Jun
Division of Cardiothoracic Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, Rhode Island.
Division of Cardiothoracic Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, Rhode Island.
J Surg Res. 2018 Oct;230:80-86. doi: 10.1016/j.jss.2018.04.045. Epub 2018 May 22.
We have previously found that hyperkalemic cardioplegic arrest in the setting of cardiopulmonary bypass (CP/CPB) is associated with impairment of the coronary arteriolar response to phenylephrine in nondiabetic (ND) patients. We hypothesized that diabetes may alter coronary arteriolar response to alpha-1 adrenergic agonist in the setting of CP/CPB. In this study, we further investigated the effects of diabetes on the altered coronary arteriolar response to phenylephrine in patients undergoing cardiac surgery.
Coronary arterioles (90-150 μm in diameter) were harvested pre- and post-CP/CPB from the ND and diabetic mellitus (DM) patients (n = 8/group) undergoing cardiac surgery. In-vitro microvascular reactivity was examined in response to phenylephrine. The protein expression/localization of the alpha-1 adrenergic receptors in the atrial myocardium was measured by Western blotting and immunohistochemistry.
Phenylephrine (10 to 10 M) induced a dose-dependent contractile response in both ND and DM vessels pre- and post-CP/CPB. There was no significant difference in the pre-CP/CPB contractile responses to phenylephrine between ND and DM groups. The post-CP/CPB contractile response was significantly diminished in both ND and DM groups compared with the respective pre-CP/CPB response (P < 0.05 versus pre-CP/CPB). This diminished contractile response was more pronounced in vessels from DM patients compared with vessels from ND patients (P < 0.05 versus ND). There were no significant differences in the protein expression of alpha-1A and alpha-1B receptors in the atrial myocardium between the ND and DM groups or tissue harvested pre- or post-CP/CPB.
Diabetes is associated with a decreased contractile response of coronary arterioles to phenylephrine in the setting of CP/CPB versus that observed in ND patients. This alteration may contribute to the vasomotor dysfunction of coronary microcirculation seen early after CP/CPB in patients with diabetes.
我们之前发现,在非糖尿病(ND)患者中,体外循环(CP/CPB)期间的高钾停搏与冠状动脉小动脉对去氧肾上腺素的反应受损有关。我们推测,糖尿病可能会改变CP/CPB期间冠状动脉小动脉对α-1肾上腺素能激动剂的反应。在本研究中,我们进一步调查了糖尿病对接受心脏手术患者冠状动脉小动脉对去氧肾上腺素反应改变的影响。
从接受心脏手术的ND和糖尿病(DM)患者(每组n = 8)的CP/CPB前后采集冠状动脉小动脉(直径90 - 150μm)。检测体外微血管对去氧肾上腺素的反应性。通过蛋白质印迹法和免疫组织化学法测量心房心肌中α-1肾上腺素能受体的蛋白表达/定位。
去氧肾上腺素(10至10 M)在CP/CPB前后均在ND和DM血管中诱导剂量依赖性收缩反应。ND组和DM组在CP/CPB前对去氧肾上腺素的收缩反应无显著差异。与各自的CP/CPB前反应相比,ND组和DM组的CP/CPB后收缩反应均显著减弱(与CP/CPB前相比,P < 0.05)。与ND患者的血管相比,DM患者血管中这种减弱的收缩反应更明显(与ND相比,P < 0.05)。ND组和DM组之间或CP/CPB前后采集的组织中,心房心肌中α-1A和α-1B受体的蛋白表达无显著差异。
与ND患者相比,糖尿病与CP/CPB期间冠状动脉小动脉对去氧肾上腺素的收缩反应降低有关。这种改变可能导致糖尿病患者CP/CPB后早期出现的冠状动脉微循环血管舒缩功能障碍。